Instrument Inactif

Communiqués Cannabics Pharmaceuticals Inc. Other OTC

Actions

CNBX

US13764M1009

Recherche biotechnologique et médicale

Communiqués

01/12	CNBX Pharmaceuticals : Annual Report for Fiscal Year Ending August 31, 2025 (Form 10-K)	PU
29/11/24	CNBX Pharmaceuticals : Annual Report for Fiscal Year Ending August 31, 2024 (Form 10-K)	PU
14/04/23	CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
08/02/23	CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	AQ
13/01/23	CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
29/12/22	CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	AQ
30/11/22	CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
08/11/22	CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma	PR
18/10/22	CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy	PR
13/10/22	CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel	PR
29/09/22	CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate	PR
28/09/22	CNBX Pharmaceuticals Announces New Patent Granted in Australia	PR
25/07/22	CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	AQ
14/07/22	CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
31/05/22	CNBX Pharmaceuticals Release a New Corporate Presentation	PR
05/05/22	CNBX Pharmaceuticals Granted Patent in Hong Kong	PR
12/04/22	CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
28/03/22	Cannabics Pharmaceuticals : Changes Name to CNBX Pharmaceuticals - Form 8-K	PU
28/03/22	CNBX PHARMACEUTICALS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
28/03/22	Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals	PR
16/03/22	CANNABICS PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	AQ
17/02/22	CANNABICS PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
13/01/22	CANNABICS PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
29/11/21	CANNABICS PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
19/11/21	CANNABICS PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	AQ